Gossamer Bio, Inc. (GOSS)
2.33
+0.07
(+3.10%)
USD |
NASDAQ |
Feb 10, 16:00
2.38
+0.05
(+2.15%)
After-Hours: 20:00
Gossamer Bio Market Cap : 539.29M for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 10.87B |
| XOMA Royalty Corp. | 283.45M |
| Rezolute, Inc. | 284.67M |
| Axsome Therapeutics, Inc. | 9.291B |
| Crinetics Pharmaceuticals, Inc. | 4.881B |
Market Cap Related Metrics
| PS Ratio | 12.02 |
| PEG Ratio | -0.0311 |
| Price | 2.33 |
| Earnings Yield | -29.49% |
| PEGY Ratio | -0.0311 |